Orchestra BioMed Holdings, Inc. Income Statement

Income Statement Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 3.53M2.76M2.64M
Gross Profit 3.32M2.57M2.43M
Operating items
Depreciation & Amortization - Total 0.29M0.31M
Research & Development 21.95M33.82M42.80M
Wages, Salaries and Other 20.77M22.60M
Selling, General & Administrative 14.03M20.26M23.93M
Other Operating Expenses -0.95M2.39M3.28M
Operating Expenses 36.19M54.27M66.94M
Operating Income -32.66M-51.51M-64.30M
EBIT -32.66M-51.51M-64.30M
Non-operating items
Non Operating Investment Income 1.03M-0.02M-0.07M
Interest & Investment Income 3.85M3.36M
Other Non Operating Income -0.68M-1.20M-0.01M
Non Operating Income -0.01M
Net income details
EBT -32.66M-47.66M-60.95M
Profit After Tax -33.61M-49.12M-61.02M
Income from Continuing Operations -32.66M-47.66M-60.95M
Consolidated Net Income -32.66M-47.66M-60.95M
Income towards Parent Company -32.66M-47.66M-60.95M
Net Income towards Common Stockholders -32.66M-47.66M-60.95M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 30.63M35.74M38.01M
Shares Outstanding (Diluted Average) 14.99M33.23M36.82M
EBITDA -33.62M-49.12M-60.96M
Shares Outstanding 35.69M35.78M38.19M